Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The Use of Life-Sustaining Procedures in the Last Month of Life Is Associated With More Depressive Symptoms in Surviving Spouses.

Ornstein KA, Aldridge MD, Garrido MM, Gorges R, Bollens-Lund E, Siu AL, Langa KM, Kelley AS.

J Pain Symptom Manage. 2017 Feb;53(2):178-187.e1. doi: 10.1016/j.jpainsymman.2016.08.023. Epub 2016 Nov 15.

PMID:
27864126
2.

Regulating and Paying for Hospice and Palliative Care: Reflections on the Medicare Hospice Benefit.

Mor V, Teno JM.

J Health Polit Policy Law. 2016 Aug;41(4):697-716. doi: 10.1215/03616878-3620893. Epub 2016 Apr 28.

PMID:
27127256
3.

Trends in end-of-life cancer care in the Medicare program.

Wang SY, Hall J, Pollack CE, Adelson K, Bradley EH, Long JB, Gross CP.

J Geriatr Oncol. 2016 Mar;7(2):116-25. doi: 10.1016/j.jgo.2015.11.007. Epub 2016 Jan 15.

PMID:
26783015
4.

Trends in in-hospital cardiopulmonary resuscitation and survival in adults receiving maintenance dialysis.

Wong SP, Kreuter W, Curtis JR, Hall YN, O'Hare AM.

JAMA Intern Med. 2015 Jun;175(6):1028-35. doi: 10.1001/jamainternmed.2015.0406.

6.

Cancer spending and accountable care organizations: Evidence from the Physician Group Practice Demonstration.

Colla CH, Lewis VA, Gottlieb DJ, Fisher ES.

Healthc (Amst). 2013 Dec 1;1(3-4):100-107.

7.

Geographic variation in fee-for-service medicare beneficiaries' medical costs is largely explained by disease burden.

Reschovsky JD, Hadley J, Romano PS.

Med Care Res Rev. 2013 Oct;70(5):542-63. doi: 10.1177/1077558713487771. Epub 2013 May 28.

PMID:
23715403
8.

Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.

Teno JM, Gozalo PL, Bynum JP, Leland NE, Miller SC, Morden NE, Scupp T, Goodman DC, Mor V.

JAMA. 2013 Feb 6;309(5):470-7. doi: 10.1001/jama.2012.207624.

9.

Impact of payment reform on chemotherapy at the end of life.

Colla CH, Morden NE, Skinner JS, Hoverman JR, Meara E.

J Oncol Pract. 2012 May;8(3 Suppl):e6s-e13s. doi: 10.1200/JOP.2012.000539.

10.

Impact of payment reform on chemotherapy at the end of life.

Colla CH, Morden NE, Skinner JS, Hoverman JR, Meara E.

Am J Manag Care. 2012 May 1;18(5):e200-8.

11.

A prospective cohort study of long-term cognitive changes in older Medicare beneficiaries.

Wolinsky FD, Bentler SE, Hockenberry J, Jones MP, Weigel PA, Kaskie B, Wallace RB.

BMC Public Health. 2011 Sep 20;11:710. doi: 10.1186/1471-2458-11-710.

12.
13.

Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.

Fahlman C, Lynn J, Doberman D, Gabel J, Finch M.

J Palliat Med. 2006 Aug;9(4):884-93.

PMID:
16910803
14.

Trends in the treatment of acute myeloid leukaemia in the elderly.

Lang K, Earle CC, Foster T, Dixon D, Van Gool R, Menzin J.

Drugs Aging. 2005;22(11):943-55.

PMID:
16323971
15.

The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care.

Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL.

Ann Intern Med. 2003 Feb 18;138(4):288-98.

PMID:
12585826
16.

Longevity and health care expenditures: the real reasons older people spend more.

Yang Z, Norton EC, Stearns SC.

J Gerontol B Psychol Sci Soc Sci. 2003 Jan;58(1):S2-10.

PMID:
12496303
17.

MediCaring: development and test marketing of a supportive care benefit for older people.

Lynn J, O'Connor MA, Dulac JD, Roach MJ, Ross CS, Wasson JH.

J Am Geriatr Soc. 1999 Sep;47(9):1058-64.

PMID:
10484246
18.

The special health care needs of the elderly.

Moon M.

Baxter Health Policy Rev. 1996;2:317-49.

PMID:
11066264

Supplemental Content

Loading ...
Support Center